Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice

Given that human Campylobacter jejuni infections are rising globally and antibiotic treatment is not recommended, infected patients would substantially benefit from alternative therapeutic strategies. Short-chain fatty acids such as butyrate are known for their health benefits, including anti-microb...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Ke, Foote, Minnja S., Mousavi, Soraya, Buczkowski, Agnes, Schmidt, Sebastian, Bereswill, Stefan, Heimesaat, Markus M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609162/
https://www.ncbi.nlm.nih.gov/pubmed/36296229
http://dx.doi.org/10.3390/microorganisms10101953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609162/
https://www.ncbi.nlm.nih.gov/pubmed/36296229
http://dx.doi.org/10.3390/microorganisms10101953

Ejemplares similares